Replies to post #295129 on Elite Pharmaceuticals Inc (ELTP)

[Don'tDrinkTheKoolAid]

All 8 approvals might get it there. It would take a miracle to get 8 approvals. Then again the one's to get the CRL's will be the MONSTERS! So this might get to .20 with all the generics approved.
With nasRAT's 1st attempt at approval 100% are getting CRL's so there goes that. 25% might get approved on the 1st try.

[WeeZuhl]

10? 20? 30? WeeZuhl would be the one to ask to get the best answer for this topic.

I also got a few PM's re: this issue of how many competitors for generic Percocet. Unfortunately, it is impossible for me to answer this question. The reason is because it would require me to give a crap, which I don't. Just start making that shit and sell it cheap. Generic success is all about price. The lower the price, the more clicks by pharmacy buyers.


Percocet approval marks an important transition for Elite. There are many competitors for Percocet because it is a big-selling drug. All of ELTP's currently-approved ANDA's are niche products with only a few competitors. Hopefully, there will be a handful more big drug ANDA approvals to follow in the next few years, but currently, they have nothing else like it in the portfolio. So, Percocet is an important test for Nasrat and team. They have our factory ready. They have our first big drug approval. Now what can they do?


How many competitors? Don't care. How competitive? That's the question.